Sequoia Financial Advisors, LLC Harpoon Therapeutics, Inc. Transaction History

Sequoia Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.55 - $0.82 $19,824 - $29,556	-36,045 Reduced 36.05%	63,955 $45,000
Q1 2023 Apr 24, 2023	BUY	$0.65 - $1.37 $26,000 - $54,800	40,000 Added 66.67%	100,000 $74,000
Q4 2022 Jan 17, 2023	BUY	$0.6 - $1.41 $36,000 - $84,600	60,000 New	60,000 $0
Q2 2022 Jul 22, 2022	BUY	$1.78 - $5.02 $5,340 - $15,059	3,000 Added 22.73%	16,200 $31,000
Q1 2022 May 13, 2022	BUY	$3.54 - $8.08 $46,728 - $106,656	13,200 New	13,200 $66,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.